Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas, Yaskawa Discuss Potential Creation of Innovative Cell Therapy Ecosystem | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Astellas, Yaskawa Discuss Potential Creation of Innovative Cell Therapy Ecosystem

Aim to seamlessly link early-stage research to commercialization to manufacture high-quality products and shorten the R&D period of cell therapy.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Astellas Pharma Inc. has signed a memorandum of understanding with Yaskawa Electric Corporation to begin discussions about creating an innovative cell therapy ecosystem through the integration of pharmaceutical and robotics technologies.
 
This memorandum is legally non-binding and will lead to further specific discussions between the two companies in the future.
 
Under the terms of the memorandum, the companies will begin discussions to potentially develop a platform that may seamlessly link early-stage research to commercialization, utilizing the dual-armed, humanoid robot “Maholo,” which Astellas installed in 2017, to manufacture high-quality products and shorten the R&D period of cell therapy.
 
Furthermore, the companies would consider the possibility of offering the platform to startups and academia, aiming to develop an advanced cell therapy ecosystem that may enable the discovery and nurturing of innovation while potentially reducing investment in investigational drug manufacturing based on the Pharmaceutical and Medical Device Act.
 
Astellas would provide cell manufacturing technology, clinical development and regulatory insights related to cell therapy. Yaskawa would provide and develop robotics and factory automation technologies.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics